voriconazole has been researched along with Cytomegalic Inclusion Disease in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Barthelmess, EK; Chen, TT; David, AP; MacBrayne, CE | 1 |
Doke, Y; Fukuda, T; Fukushi, Y; Hashimoto, H; Inamoto, Y; Nakashima, T; Yamaguchi, M | 1 |
Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C | 1 |
Gundlapalli, S; Gupta, KL; Kaur, H; Kohli, HS; Kumar, V; Mohindra, S; Ramachandran, R; Rathi, M; Sakhuja, V | 1 |
Ahn, KS; Hwang, JS; Jang, BK; Kang, KJ; Kang, YN; Kim, HT; Kim, IM; Kim, TS; Kim, YH | 1 |
Manavathu, EK; Vazquez, JA | 1 |
Chen, MH; Crespo, M; Humar, A; Husain, S; Kumar, D; Manuel, O; McCurry, KR; Moussa, G; Pilewski, J; Studer, SM | 1 |
Karaahmet, T; Korten, V; Odabasi, Z; Tigen, E; Tigen, K | 1 |
Bermudez, C; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A | 1 |
Rokicka, M | 1 |
Griffiths, PD | 1 |
1 trial(s) available for voriconazole and Cytomegalic Inclusion Disease
Article | Year |
---|---|
Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation.
Topics: Acetates; Adult; Aged; Allografts; Cytomegalovirus; Cytomegalovirus Infections; Drug Interactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Quinazolines; Retrospective Studies; Voriconazole | 2021 |
10 other study(ies) available for voriconazole and Cytomegalic Inclusion Disease
Article | Year |
---|---|
Letermovir for Cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation.
Topics: Adult; Antiviral Agents; Child; Cohort Studies; Cyclosporins; Cytomegalovirus; Cytomegalovirus Infections; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies; Transplant Recipients; Voriconazole | 2023 |
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult | 2014 |
A rare case of Cytomegalovirus, Scedosporium apiospermum and Mycobacterium tuberculosis in a renal transplant recipient.
Topics: Antifungal Agents; Antitubercular Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Developing Countries; Female; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Mycobacterium tuberculosis; Mycoses; Postoperative Complications; Scedosporium; Transplant Recipients; Transplantation, Homologous; Tuberculosis; Voriconazole | 2014 |
Successful Treatment of Combined Aspergillus and Cytomegalovirus Abscess in Brain and Lung After Liver Transplant for Toxic Fulminant Hepatitis.
Topics: Antifungal Agents; Biopsy; Brain Abscess; Chemical and Drug Induced Liver Injury; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Liver Transplantation; Lung Abscess; Magnetic Resonance Imaging; Middle Aged; Mushroom Poisoning; Neuroaspergillosis; Neurosurgical Procedures; Opportunistic Infections; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2017 |
Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Cytomegalovirus Infections; Drug Resistance, Fungal; Fungal Proteins; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Transplant Recipients; Triazoles; United States; Voriconazole | 2016 |
Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
Topics: Adult; Antifungal Agents; Antiviral Agents; Bronchiolitis Obliterans; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Graft Rejection; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Pyrimidines; Syndrome; Triazoles; Valganciclovir; Voriconazole | 2009 |
Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: early diagnosis is the key to successful treatment.
Topics: Acute Disease; Antifungal Agents; Antiviral Agents; Cardiomyopathy, Dilated; Cytomegalovirus Infections; Early Diagnosis; Ganciclovir; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Opportunistic Infections; Pulse Therapy, Drug; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antiviral Agents; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Pyrimidines; Reoperation; Retrospective Studies; Survivors; Time Factors; Tissue Donors; Triazoles; Valganciclovir; Voriconazole | 2010 |
AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation.
Topics: Adult; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Combined Modality Therapy; Cytarabine; Cytomegalovirus Infections; Enterococcus faecalis; Fatal Outcome; Humans; Idarubicin; Immunocompromised Host; Immunoglobulins, Intravenous; Liposomes; Male; Mycoses; Peripheral Blood Stem Cell Transplantation; Pneumonia; Postoperative Complications; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas putida; Pulmonary Edema; Pyrimidines; Sinusitis; Staphylococcus epidermidis; Transplantation, Autologous; Triazoles; Voriconazole | 2006 |
The 2001 Garrod lecture. The treatment of cytomegalovirus infection.
Topics: Antifungal Agents; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Infections; Humans; Immunity, Cellular; Pyrimidines; Triazoles; Voriconazole | 2002 |